Bellone M, Sabinot A, D’Arpino A, Omodeo Salè E, Ghislieri D, Pradelli L. A 1-year per-patient cost of therapy administration analysis of mosunetuzumab and tisagenlecleucel in relapsed or refractory follicular lymphoma patients receiving two or more lines of systemic therapy. Grhta [Internet]. 2024 Dec. 9 [cited 2025 Mar. 31];11(1):239-47. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/3170